Business Wire

2021 COMPUTEX Forum Day 2: Unlocking Next-Generation Technologies

4.6.2021 13:03:00 EEST | Business Wire | Press release

Share

The second day of COMPUTEX Forum, organized by TAITRA, featured "Critical Technology" and "Tomorrow Tech." World-renown tech leaders such as Qualcomm, QCT, WIN Semiconductors Corp., Siemens, Far EasTone Telecom, NVIDIA, and IBM shared their perspectives on the latest development of 5G, AI & IoT, and quantum computing, as well as their strategies for navigating in the new normal.

Cynthia Kiang, Director General of the Bureau of Foreign Trade, MOEA, Taiwan, said in her opening remarks that the recent global chip shortage underscores the importance of supply chain resilience, and that international cooperation is the best way to ensure supply chain efficiency and stability. She expects COMPUTEX to be a platform that helps with integrating global resources, allowing ecosystem partners to explore future business opportunities.

Qualcomm: Empowering the future of PC with mobile computing

With the onset of the pandemic and shift to remote working and learning, the way people use PCs has rapidly expanded. Alex Katouzian, Senior Vice President and General Manager of Mobile, Compute, and Infrastructure for Qualcomm Technologies, shared his unique perspectives on how 5G along with always connected PC are facilitating connectivity, mobility, and productivity as PC becomes the best collaborative tool in a mobile office. Qualcomm will also continue to collaborate with its ecosystem partners to realize the future of always connected PC.

QCT: 5G New Era: Great Convergence, Broad Ecosystem, Golden Opportunity

Mike Yang, President of QCT, talks about the great convergence of IT and CT, and the many new entrants into the Telco ecosystem that are changing our daily lives. With them more and more service providers will push for digital transformation and build 5G networks that will open up new opportunities for everyone, including operators and enterprises.

WIN Semiconductors Corp: Shaping the future with compound semiconductors

Dr. Yu-Chi (YC) Wang, Vice Chairman of WIN Semiconductors Corp emphasized that compound semiconductors are essential in realizing a life style built on seamless connection, precise sensing, and efficiency power. In addition, future life will be based on ubiquitous AI access with 6G, super IoT, and AI. Compound semiconductor will play a pivotal role to advance that future.

Siemens: Industrial 5G, Grid Edge and Connected Mobility will accelerate smart economy development and drive industrial innovation and transformation

Taiwan is crucial in the global supply chain of ICT components with a comprehensive industrial value chain. Erdal Elver, President and CEO of Siemens Taiwan pointed out that Taiwan has a clear advantage in introducing 5G innovative applications in manufacturing and city infrastructure. Siemens’ world-leading technologies and success stories in Industrial 5G, Grid Edge and Connected Mobility will assist Taiwan in ushering in application innovation in a variety of fields, helping Taiwan move toward its vision of "Digital Nation, Smart Island."

Far EasTone Telecom: Enabling clinical intelligence through telemedicine with 5G, IoT, big data, and AI

Chee Ching, President of Far EasTone Telecom, discussed medical applications in the 5G era. Telemedicine supported by 5G is capable of diagnosing patients remotely through features such as high resolution, big bandwidth, low latency, and massive connectivity. Telemedicine will also be able to detect and prevent diseases using big data and AIoT, ushering a new era of smart medicine. Chee Ching also pointed out that long-term care will be the extended application field for telehealth. With Taiwan expected to become a super-aged society by 2026, Far EasTone Telecom views this not only as a business opportunity but also as a social responsibility.

NVIDIA: Empowering collaboration across shared virtual worlds by addressing 3D workflows

Richard Kerris, NVIDIA Head of Worldwide Developer Relations and General Manager of Omniverse, indicated that a distributed workforce has become the norm with the rise of hybrid work. Remote working, however, has deepened the challenges of 3D workflows. NVIDIA Omniverse, the revolutionary new platform for virtual collaboration and simulation, can empower individuals and companies across multiple industries to address the challenges of complex 3D workflows by connecting users, content creation tools, and enabling AI to be used across shared virtual worlds.

IBM: Quantum computing

Norishige Morimoto, Vice President of IBM Research and Development of Japan, stated that quantum computing has yet to overcome obstacles on hardware and application development before becoming available for all. Now, IBM is collaborating with industry and universities including NTU, focusing on finance, chemistry, material industries.

2021 COMPUTEX Forum and keynote speeches are all available for viewing on #COMPUTEXVirtual online platform and COMPUTEX YouTube channel from now.

For more information:

COMPUTEX : https://www.computextaipei.com.tw/

InnoVEX : https://www.innovex.com.tw/

About COMPUTEX

Established in 1981, COMPUTEX is one of the leading global ICT, IoT, and startup tradeshows with a complete supply chain and IoT ecosystems. Co-organized by the Taiwan External Trade Development Council (TAITRA) and Taipei Computer Association (TCA), COMPUTEX, based upon Taiwan’s complete ICT clusters, covers the whole spectrum of the ICT industry, from established brands to startups and from ICT supply chain to IoT ecosystems. With strong R&D and manufacturing capabilities and IPR protection, Taiwan is a strategic destination for foreign companies and investors looking for partners in global technology ecosystems. Follow COMPUTEX on its website at www.computextaipei.com.tw and Twitter @computex_taipei using the hashtag #COMPUTEX.

About COMPUTEX 2021 Virtual

As a pioneer in technology, COMPUTEX has been at the forefront in embracing digital transformation. In 2021, the show will go online. Together with the key global technology players, the organizer of COMPUTEX,Taiwan External Trade Development Council (TAITRA) introduces #COMPUTEXVirtual (including its global startups and innovations showcase #InnovexVirtual), an AI-driven virtual platform, and aims to deliver an exceptional virtual exhibition experience beyond the distance.

Explore #COMPUTEXVirtual now at https://virtual.computextaipei.com.tw/.

About TAITRA

Founded in 1970, TAITRA is Taiwan's foremost nonprofit trade promoting organization. Sponsored by the government and industry organizations, TAITRA assists enterprises to expand their global reach. Headquartered in Taipei, TAITRA has a team of 1,300 specialists and operates 5 local offices in Taoyuan, Hsinchu, Taichung, Tainan and Kaohsiung, as well as 63 branches worldwide. Together with Taipei World Trade Center (TWTC) and Taiwan Trade Center (TTC), TAITRA has formed a global network dedicated to promoting world trade.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Press:
Ms. Tessa Lin <tessalin@taitra.org.tw>
Ms. Li Chao < lichao@taitra.org.tw>

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

LabPMM® Launches Global KMT2A MRD Testing Service to Support Menin Inhibitor Development and Acute Leukemia Care4.8.2026 10:10:00 EEST | Press release

LabPMM®, an Invivoscribe® subsidiary, today announced the global availability of its new KMT2A measurable residual disease (MRD) testing service. The highly sensitive digital PCR service is available to healthcare providers, clinical researchers, and biopharmaceutical partners through LabPMM’s global laboratory network, with CAP/CLIA-accredited testing available in the U.S. The service addresses a growing need for accurate molecular monitoring in acute leukemias.1,2,3 KMT2A rearrangements (KMT2Ar) are oncogenic drivers in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).4 These rearrangements are present in about 80% of infant cases and 5-15% of childhood and adult leukemia cases.5 KMT2Ar leukemias are associated with chemotherapy resistance, high relapse rates, and poor clinical outcomes.5 The emergence of menin inhibitors is transforming the therapeutic landscape for patients with AML and ALL, particularly those with KMT2A-rearranged and NPM1-mutated disease.6 The

Mosaic Therapeutics appoints Dr Allison Jeynes as Chair of the Board4.8.2026 10:00:00 EEST | Press release

Mosaic Therapeutics, Ltd, (‘Mosaic’, or ‘the Company’) an oncology therapeutics company developing novel, targeted drug combinations across a range of haematological and solid cancers, today announced the appointment of Dr Allison Jeynes as Chair of the Board to support its next phase of growth and advancement towards clinical development. Allison succeeds Dr Edward Hodgkin, who remains a Non-Executive Director of the Board. Allison is a UK-trained oncologist and highly-experienced life sciences leader, and brings over three decades of drug development and executive experience to Mosaic Therapeutics. As CEO of Avillion, a clinical development company, for the last 13 years, she has led global teams to achieve a 100% success rate from Phase 3 development through to FDA approval for multiple programs spanning oncology, immunology and respiratory medicine. In addition, she raised funds of around $400M as founder and CEO. Across her career she has contributed to 20 drug approvals, engaging

TOHKnet and Adtran conduct Japan’s first 50G PON trial on a live network4.8.2026 10:00:00 EEST | Press release

Adtran today announced that TOHKnet has completed Japan’s first live network trial demonstrating the coexistence of 50G PON, XGS-PON and EPON on a single fiber. Conducted in Sendai using Adtran’s SDX 6400 Series OLT, the demo showed how the platform enables three generations of PON technology to operate together in a live service environment. The results highlight a realistic path for operators to introduce 50G PON capacity while maintaining continuity for existing services, maximizing the value of deployed fiber assets and reducing the complexity and disruption typically associated with network upgrades. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260803353435/en/ Adtran’s SDX 6400 Series is helping TOHKnet demonstrate how Japan’s operators can migrate to 50G PON without disrupting existing PON services. “As demand for digital services continues to grow, this trial is a key milestone for the future of fiber access in Jap

“HATSUNE MIKU LIGHTS TOKYO” Debuts on July 254.8.2026 10:00:00 EEST | Press release

The Tokyo Metropolitan Government has been presenting year-round projection mapping displays on the Tokyo Metropolitan Government Building, using light and sound to showcase a wide range of artistic expressions as part of its efforts to create new nighttime tourism attractions in Tokyo. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260802298570/en/ © Crypton Future Media, INC. On Saturday, July 25, "HATSUNE MIKU LIGHTS TOKYO", featuring the globally beloved virtual singer Hatsune Miku, held its first screening. The work brings the world of the popular song “M@GICAL☆CURE! LOVE ♥ SHOT!” to life across the entire façade of the Tokyo Metropolitan Government Building. Since its launch in February 2024, “TOKYO Night & Light” has welcomed visitors from Japan and around the world, with total attendance surpassing 1.55 million. As one of Tokyo’s emerging landmark attractions, the project continues to captivate audiences through its

Evexta Bio Announces Clinical Trial Collaboration and Supply Agreement with Roche to Evaluate Rupitasertib in Combination with a Selective Estrogen Receptor Degrader in Advanced / Metastatic Breast Cancer4.8.2026 10:00:00 EEST | Press release

Evexta Bio S.A., a precision oncology company, founded by Truffle Capital (founder of Abivax and Carvolix), and focused on the discovery and development of targeted therapies, today announced a clinical collaboration and supply agreement with plans to initiate a Phase 1b study combining its lead investigational compound, rupitasertib, with Roche’s investigational compound giredestrant, a selective estrogen receptor degrader (SERD), for the treatment of ER+, HER2-, ESR1-mutated advanced / metastatic breast cancer. Rupitasertib, is a first-in-class oral dual-node PI3K/AKT/mTOR (PAM) pathway inhibitor, which selectively inhibits S6K and AKT1/3. Rupitasertib was purposefully and rationally designed to target S6K for potent PAM inhibition and AKT1/3 to block the AKT compensatory feedback loop, while sparing AKT2 to avoid hyperglycemia, which we believe will lead to a superior efficacy and safety profile compared to other PAM pathway inhibitors. Under the terms of the agreement, Roche will s

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye